WGS of histological samples from NSCLC tumors that underwent SCLC transformation under EGFR-TKI treatment revealed complete inactivation of tumor-suppressing genes (RB1, TP53) in both the initial NSCLC and at the newly detected SCLC. The gene discussed is EGFR; the disease is small cell lung carcinoma.